Wound Care Comfort Membrane Chitosan Wound Medical Vacuum Dressing Absorbable Surgical Chitosan Dressing Hemostatic Gauze

describe:

Chitosan hemostatic gauze is made of sterile high-density non-woven gauze coated with chitosan. The product is Z-folded.

Instructions for use:

1. Tear open the package. Prior to application, identify and apply direct pressure to the major part of the bleeding, then remove excess blood if feasible. Take out the chitosan gauze and take one end of the Z-folded gauze.
2. Wrap the unfolded chitosan gauze tightly around the source of bleeding. Wrap the remaining wound with chitosan gauze or standard gauze above the skin level.
3. If bleeding continues, apply firm, direct pressure to the wound for 1 minute or until bleeding stops.
4. If necessary, the excess chitosan gauze can be torn off or cut off. Wrap and tie a bandage tightly to maintain pressure on the wound.
5. Dispose of any remaining chitosan gauze according to local biowaste standard protocols.
6. Transfer the patient to a medical facility as soon as possible.
7. Show the empty package to the medical staff.

Precautions:

- For external use only.
-do not eat. If ingested, drink a glass of water to avoid discomfort.
- Loss of sterility may present a risk of infection. Do not re-sterilize.
-Avoid inhalation. Do not apply to eyes. In case of eye irritation, flush with water for 5 minutes.
- Stay away from children.
- Reuse may cause risk of cross-contamination and decreased performance.

The device and residue should be removed from the wound within 24 hours of application.

Storage conditions:
Keep dry. Keep away from heat sources, including storing in direct sunlight or direct contact with heat sources. Store at 77°F (25°C) or below.

Sterilization and expiration date:
Product is sterilized by exposure to gamma radiation and is intended for single use only. Do not re-sterilize. Do not use if pouch is damaged or opened.
Do not use the device after the expiry date listed on the packaging.

Any serious incidents involving equipment should be reported to the manufacturer and to competent personnel
Authorities in the Member State where the user and/or patient is located.